Cargando…

Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases

BACKGROUND: Systemic inflammation measured by the neutrophil-to-lymphocyte ratio (NLR), leucocyte-to-lymphocyte ratio (LLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR) and CRP/albumin ratio (CRP/Alb) was shown to impact the survival prognosis in patients with extracranial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Starzer, Angelika M., Steindl, Ariane, Mair, Maximilian J., Deischinger, Carola, Simonovska, Anika, Widhalm, Georg, Gatterbauer, Brigitte, Dieckmann, Karin, Heller, Gerwin, Preusser, Matthias, Berghoff, Anna S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007827/ https://www.ncbi.nlm.nih.gov/pubmed/33473170 http://dx.doi.org/10.1038/s41416-020-01254-0

Ejemplares similares

Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort
por: Steindl, Ariane, et al.
Publicado: (2019)

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer
por: Wolff, Ladislaia, et al.
Publicado: (2023)

Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non–small cell lung cancer brain metastases
por: Steindl, Ariane, et al.
Publicado: (2020)

Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases
por: Furtner, Julia, et al.
Publicado: (2018)

Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
por: Steindl, A., et al.
Publicado: (2021)

Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases
por: Furtner, Julia, et al.
Publicado: (2017)

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers
por: Berghoff, Anna S, et al.
Publicado: (2016)

Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
por: Bergen, Elisabeth Sophie, et al.
Publicado: (2021)

Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles
por: Steindl, Ariane, et al.
Publicado: (2021)

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center
por: Füreder, L. M., et al.
Publicado: (2018)

Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours
por: Mair, Maximilian J, et al.
Publicado: (2020)

High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases
por: Leitner, Johannes, et al.
Publicado: (2018)

Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
por: Starzer, Angelika M., et al.
Publicado: (2022)

LAG-3 expression in the inflammatory microenvironment of glioma
por: Mair, Maximilian J., et al.
Publicado: (2021)

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma
por: Mair, Maximilian J., et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
por: Fuereder, Thorsten, et al.
Publicado: (2020)

Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma
por: Mair, Maximilian J., et al.
Publicado: (2021)

Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases
por: Bergen, E.S., et al.
Publicado: (2021)

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
por: Bartsch, Rupert, et al.
Publicado: (2022)

New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
por: Starzer, Angelika M., et al.
Publicado: (2020)

Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival Times
por: Berghoff, Anna Sophie, et al.
Publicado: (2013)

Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)
por: Oing, Christoph, et al.
Publicado: (2020)

New developments in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
por: Mair, Maximilian J., et al.
Publicado: (2023)

Brain metastases from hepatopancreatobiliary malignancies
por: Bergen, Elisabeth S., et al.
Publicado: (2023)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
por: Starzer, Angelika Martina, et al.
Publicado: (2022)

Anti-angiogenic therapies in brain metastases
por: Berghoff, Anna S., et al.
Publicado: (2018)

Targeted Therapies for Melanoma Brain Metastases
por: Berghoff, Anna S., et al.
Publicado: (2017)

Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature
por: Leibetseder, Annette, et al.
Publicado: (2021)

Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation
por: Steindl, Ariane, et al.
Publicado: (2020)

Emerging systemic treatment options in meningioma
por: Mair, Maximilian J., et al.
Publicado: (2022)

SURG-13. EVALUATION OF 5-ALA FLUORESCENCE IN BRAIN METASTASES OF VARIOUS PRIMARY TUMORS: A MULTICENTER STUDY WITH EXPERIENCE IN 157 CASES
por: Mercea, Petra Andreea, et al.
Publicado: (2019)

Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
por: Starzer, Angelika M, et al.
Publicado: (2021)

Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis
por: Puhr, Hannah C., et al.
Publicado: (2021)

Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling
por: Furtner, Julia, et al.
Publicado: (2019)

Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma
por: Preusser, Matthias, et al.
Publicado: (2014)

Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee
por: Kiesel, Barbara, et al.
Publicado: (2020)

Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases
por: Mercea, Petra A., et al.
Publicado: (2021)

ACT-26 ABT-414 (DEPATUX-M) IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: WHERE DO WE STAND?
por: Preusser, Matthias
Publicado: (2019)

Frequency and Prognosis of Pulmonary Metastases in Newly Diagnosed Gastric Cancer
por: Sun, Zepang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kctl1f67455g3l431akcquqs8f